STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Stemtech Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $207.74K
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Stemtech has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Stemtech filed with the SEC
Corporation and Seacret Direct / Viago Execute Merger Agreement
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
STEMTECH CORPORATION / VIAGO AND
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K